ON24 , a leading intelligent engagement platform for B2B sales and marketing, today announced it has been ranked the leading provider in the Enterprise Grid® for Webinar Platforms in the G2 Spring ...

Equity Insider News Commentary Issued on behalf of Safety Shot, Inc. VANCOUVER, B.C., April 25, 2025 /PRNewswire/ -- Equity Insider News Commentary - The way people consume ...

Hypertension is a major public health concern, affecting millions worldwide and increasing the risk of heart disease, stroke, and kidney failure.

Bladder health and lower urinary tract issues are examples of topics not well studied. A new study focused on the association of menopause status and use of hormones with bladder and urinary tract ...

CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) are pleased to announce that the European Commission has approved ...

IgA nephropathy (IgAN) is an autoimmune disorder that affects the kidneys by impairing the filtration function of the small ...

Healy called the initiative — the largest women’s health prevention study in the U.S. — a “moon walk” for women. The purpose of the long-term project was to research cancer, heart ...

Some patients diagnosed with certain types of cancer may soon have the options to skip chemotherapy, radiation and surgery in favor of immunotherapy treatment, according to a new study published ...

DelveInsight's "FABHALTA Market Size, Forecast, and Market Insight Report" highlights the details around FABHALTA, an oral ...

Meanwhile, two-thirds of employees believe that AI can advance their careers. For the study, Microsoft drew on a survey, telemetry data from Microsoft 365 and labor market trends recorded by LinkedIn.

The Seattle Mariners placed right-handed starter Logan Gilbert on the injured list on Saturday with a flexor strain in his pitching elbow. Gilbert suffered the injury during Friday's start against ...

European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN) Decision follows positive recommendation ...